发明名称 Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
摘要 The present invention is directed to the substantially pure compound of formula (A), or pharmaceutically acceptable salt, or solvate of said compound; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (A), and a pharmaceutically acceptable carrier; and the use of a compound of formula (A) having activity as an inhibitor, preferably a selective inhibitor, of IkappaB (IKK), particularly IKK-2, and methods related thereto.
申请公布号 US2007142417(A1) 申请公布日期 2007.06.21
申请号 US20060559159 申请日期 2006.11.13
申请人 AVENTIS PHARMACEUTICALS INC 发明人 HADDAD EL-BDAOUI;RITZELER OLAF;ALDOUS DAVID J.;COX PAUL J.
分类号 A61K31/506;C07D403/14 主分类号 A61K31/506
代理机构 代理人
主权项
地址